SEC Form 4 · accession 0001213900-26-098774
Tenon Medical, Inc. · TNON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Williamson
Officer — Chief Financial Officer
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001560293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2026 | M | 30 | $0.00 | A | 2,591 | D | |
| Common StockF3 | Sep 9, 2026 | F | 11 | $3.45 | D | 2,580 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Sep 8, 2026 | M | 30 | D | — | — | Common Stock | 30 | 60 | D |
Explanation of responses
- F1Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- F3These shares were sold to pay tax liability associated with the vesting of RSUs.